Anti-JCV Antibody Prevalence in a French Cohort of MS Patients under Natalizumab

被引：0
|
作者：
Outteryck, Olivier [1 ]
Ongagna, Jean-Claude [2 ]
Zephir, Helene [1 ]
Collongues, Nicolas [2 ]
Lacour, Arnaud [1 ]
Fleury, Marie [2 ]
Berteloot, Anne-Sophie [1 ]
Blanc, Frederic [2 ]
Giroux, Marianne [1 ]
Vermersch, Patrick [1 ]
De Seze, Jerome [2 ]
机构：
[1] Univ Lille Nord France, Lille, France
[2] Univ Strasbourg, Strasbourg, France
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P02141
引用
收藏
页数：3
相关论文
共 50 条
  • [31] StratifyJCV Serum anti-JCV antibody assay for patients treated with natalizumab: quality control of sample analysis by Unilabs
    Svendsen, Sofie
    Skovgaard, Tine
    Carstensen, Kristine
    Drenth, Annemarie
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 978 - 979
  • [32] Maintaining efficacy, reinstating anti-JCV immunity in people with MS: The Natalizumab to Cladribine BartsMS experience
    Mohamed, Bader
    Meryndia, Anastasiia
    Sayali, Tatiana
    Mathews, Joela
    Baker, David
    Giovannoni, Gavin
    Schmierer, Klaus
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1048 - 1048
  • [33] Analysis of Anti-JCV antibody in Japanese patients with multiple sclerosis
    Aoyama, S.
    Mori, M.
    Uchida, T.
    Masuda, H.
    Ohtani, R.
    Sugimoto, K.
    Liu, J.
    Kuwabara, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 238 - 239
  • [34] NATALIZUMAB-RELATED PML 2 WEEKS AFTER NEGATIVE ANTI-JCV ANTIBODY ASSAY
    Brosseau, Marie-Sarah Gagne
    Stobbe, Gary
    Wundes, Annette
    NEUROLOGY, 2016, 86 (05) : 484 - 486
  • [35] StratifyJCV™ serum anti-JCV antibody assay for natalizumab patients: Unilabs global cohort data descriptive analysis and Unilabs customer satisfaction survey results
    Drenth, A.
    Carstensen, K. B.
    Morawska, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 656 - 656
  • [36] Seroprevalence and seroconversion of anti-JCV antibodies in a cohort of multiple sclerosis patients
    Gomez-Estevez, I.
    Vasco, L. Garcia
    Suarez, E. Alba
    Hernandez, M. Castro
    Sanchez, C. Bullon
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 531 - 531
  • [37] Anti-JCV antibody serostatus and longitudinal evaluation in multiple sclerosis patients
    Totaro, R.
    Danni, M.
    Evangelista, L.
    Carlini, G.
    Taffi, R.
    Cerrone, P.
    Galassi, A.
    Acciarri, M. C.
    Cerqua, R.
    Marini, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 864 - 864
  • [38] Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? Comments. Anti-JCV antibody index in multiple sclerosis care
    Stankoff, B.
    REVUE NEUROLOGIQUE, 2017, 173 (10) : 616 - 618
  • [39] NATALIZUMAB-RELATED PML 2 WEEKS AFTER NEGATIVE ANTI-JCV ANTIBODY ASSAY Response
    Brosseau, Marie-Sarah Gagne
    Stobbe, Gary
    Wundes, Annette
    NEUROLOGY, 2016, 87 (09) : 957 - 958
  • [40] The evolution of the anti-JCV antibody index value post-natalizumab: switching to fingolimod or dimethyl fumarate
    Bellengier, L.
    Cambron, M.
    Lacour, A.
    Chouraki, A.
    Duhin, E.
    Vermersch, P.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 575 - 575
12345